Abemaciclib Suppliers & Bulk Manufacturers
Available Forms: Tablets
Available Strengths: 50 mg, 100 mg, 150 mg, 200 mg
Reference Brands: Verzenio (USA/India)
Category:
Oncology Cancer Care
Abemaciclib is available in Tablets
and strengths such as 50 mg, 100 mg, 150 mg, 200 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Abemaciclib is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Abemaciclib can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Abemaciclib is a targeted anticancer medicine used in the treatment of certain types of breast cancer, particularly hormone receptor-positive (HR+), HER2-negative advanced or metastatic breast cancer. It belongs to a class of medicines known as kinase inhibitors and specifically works by blocking the activity of proteins called cyclin-dependent kinases 4 and 6 (CDK4 and CDK6). These proteins play an important role in regulating how cells grow and divide in the body. In many cancers, including breast cancer, these proteins can become overactive, leading to uncontrolled cell growth.
By inhibiting CDK4 and CDK6, Abemaciclib helps slow down or stop the multiplication of cancer cells. This action allows the treatment to control tumor progression and improve disease management in patients. Abemaciclib is considered a small-molecule drug, meaning it can easily enter cells and act directly on its target proteins inside the cancer cells. Because of this targeted mechanism, it is widely used as part of modern precision cancer therapy.
The medicine is often prescribed in combination with hormone therapy, although in some cases it may also be used alone depending on the patient’s condition and treatment plan determined by a healthcare professional.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing